when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Monoclonal Antibody · news · pharmadog

← back to Monoclonal Antibody

News · Monoclonal Antibody

333 stories

May 6, 26Avalo shares spike on skin drug data; BioNTech to cut staffbiopharma dive

May 6, 26ASCO 2026 HR+ and HER2+ Breast Cancer Preview: Read up on the Insights to Know Before You Goonclive

May 6, 26STAT+: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share pricestat

May 6, 26Disease Assessment and Mutational Testing in Progressive CLLonclive

May 6, 26Clinical Scenario Presentation and Treatment Approach for Progressive Diseaseonclive

May 6, 26Dr Pant on the Mechanism of Action of Daraxonrasib in PDAConclive

May 5, 26Dr Cohen on Frontline Chemotherapy Selection in Metastatic Pancreatic Canceronclive

May 5, 26Dr Pant on Managing Toxicities With Daraxonrasib in PDAConclive

May 5, 26STAT+: A new attack on AMA’s billing codesstat

May 5, 26Breast Cancer Experts Preview Abstracts to Watch at the 2026 ESMO Breast Cancer Congressonclive

May 5, 26The Type of Fat—Not the Amount—Fuels Pancreatic Canceronclive

May 5, 26STAT+: Are analysts too quick to gloss over Lilly’s liver case?stat

May 5, 26Dr McGregor on Key End Points of the STRIKE Trial of Tivozanib Plus Pembrolizumab in RCConclive

May 5, 26Dr Kuykendall on the Evolving JAK Inhibitor and Transplant Considerations in Myelofibrosisonclive

May 5, 26New Endometrial Targets Beyond HER2onclive

May 5, 26Coordinating Care in Multiple Myeloma Across Practice Settingsonclive

May 5, 26STAT+: Cytokinetics drug Myqorzo meets twin efficacy goals in study of genetic heart diseasestat

May 5, 26STAT+: Johnson & Johnson advances IBD therapy, despite trial missstat

May 4, 26Researchers urge study of paternal deaths, though a new paper finds fatherhood is protectivestat

May 4, 26STAT+: Pump the brakes on AI, buddy; and deposition deadlockstat

May 4, 26UCB to acquire maker of antibody treatments for autoimmune diseasesstat

May 4, 26UCB to acquire Candid in $2.2B bet on bispecifics for autoimmune diseasesbiopharma dive

May 1, 26Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlookbiopharma dive

May 1, 26J&J axes pair of CAR-T therapies for lymphoma, citing evolving marketendpoints

May 1, 26‘Forever chemicals’ in baby formula? Scientists unpack FDA resultsstat

May 1, 26Two biotechs raise a combined $556M in latest spurt of IPOsbiopharma dive

Apr 29, 26FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotechbiopharma dive

Apr 28, 26BeOne Medicines licenses trispecific antibody targeting PD-1, CTLA-4 and VEGFendpoints

Apr 27, 26Oruka surges as long-acting psoriasis drug shows early promisebiopharma dive

Apr 27, 26Compass Therapeutics unveils key secondary endpoint results from pivotal biliary tract cancer trialendpoints

← prevpage 11 of 12next →